ST. LOUIS--(BUSINESS WIRE)--Keystone Bio, a clinical-stage biotechnology company working to stop inflammatory-based disease at its source, announced today the appointment of Michael Rafii, M.D., Ph.D.
The age-old separation of dentistry from medicine is deeply embedded in education and professional practice. Given the great advances in both disciplines in recent decades, there is a reasonable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback